News

All of our latest updates

Press releases

News

April 27, 2018
The first patient has been enrolled in the LOAd703 clinical trial in Sweden, LOKON002, for the treatment of pancreatic, biliary, colorectal, and ovarian cancer.
December 2, 2016
Our LOAd703 clinical trial in LOKON001 for patients with pancreatic cancer in Houston, TX, USA has now enrolled their first patient!
July 28, 2015
EMA has granted Lokon Pharma an orphan designation status for LOAd703 immunotherapy for the treatment of pancreatic cancer.

Media

Malou efter 10
Bengt fick aggressiv cancer - hade ett år kvar att leva
Barncancerfonden
Immunterapi på 100 sekunder
Malou efter 10
Forskarna om cancervaccinet: ”Behövs pengar”
Uppsala universitet
Immunterapi är ett nytt sätt att bekämpa cancer.
Forskarpodden
Virus som dödar cancer